Skip to main content

Table 1 Follow-up of thyroid function in different hospitals

From: Drug-induced hypersensitivity syndrome induced by propylthiouracil: case report and literature review

Items before
PTU
1 month
after stopping PTU
3 month
after stopping PTU
4 months
after stopping PTU
5 months
after stopping PTU
11 months
after stopping PTU
Hospital A B C C C C
TSH 0.01 0.07 0 6.81 34.93 1.16
  0.27–4.20uIU/ml 0.34–5.6uIU/L 0.35–4.94mIU/L
FT3 15.25 3.5 6.55    
  3.1–6.80 pmol/L 3.8–6.0 pmol/L 1.71–3.71 pg/ml
FT4 71 16.2 2.23    
  12.00–22.00 pmol/L 7.9–17.1 pmol/L 0.70–1.48 ng/dl
TT3 5.46 0.94 2.42 0.86 0.76 1.32
  1.3–3.10 nmol/L 1.05–2.73 nmol/L 0.57–1.59 ng/ml
TT4 239.7 99.79 13.06 4,75 3.68 8.88
  66.00–181.00 nmol/L 78.38–170.0 nmol/L 4.87–11.72ug/dl
  1. A: local hospital; B: provincial hospital; C: our hospital
  2. FT3 free triiodothyronine, FT4 free thyroxine, PTU propylthiouracil, TSH thyroid stimulating hormone, TT3 total triiodothyronine, TT4 total thyroxin